Chronic and infiltrative growth pattern of AE lesion could result into many manifestations within the liver[4]. We have noticed the spatial heterogeneity of AE lesions at early times, and practiced much from the perspectives of diagnosis, clinical treatment and basic researches. However, the thing has not solved so far that AE lesion categorization based on radiological imaging tools. Obviously, lesion typing could help radiologists, clinicians, parasitologists to precisely evaluate and choose certain management options for patients[15–17]. An AE lesion includes various factors to be evaluated during the whole process: lesion basic or anatomical characteristics (size, location, ect.), morphology (by radiology and pathological view), calcification features (by radiology mostly), lesion biological activity (or parasitic viability), LME metabolic activity (mostly assessed by PET/CT so far), vasculature involvement (both intra- and extra-hepatic vessels including biliary trees, these are also linked with certain comorbidities to be assessed), immunological status of the patients. Among them, LME has core roles form the perspectives of anatomy, radiology, pathophysiology, and immunology.
In the past, several imaging tools demonstrated lesion types for hepatic AE[18–20]. And there were some other imaging methods and researches on comparison of different imaging tools[21–25]. These strategies had proposed new methods for lesion categorization. Nevertheless, no integrative typing system has been established so far, and they were asymmetric when defining clinical stage or lesion activity regarding different lesion types. Besides, among the lesion types that proposed by Kodama et al, Kratzer et al and Graeter et al, there were not clear integrative bridge to definitely link them, and no relevant study which used all these imaging tools in same patient cohort has been reported[18–20]. And this was why we chose to reclassify lesions based on two factors (calcification and necrosis). One of our near future studies will focus on lesion typing specifically, and will discuss about the drawbacks of each tools and optional typing system. At present, professionals have come to the conclusion that PET/CT is the valuable tool to asses lesion activity and seems to be an unreplaceable imaging method.
In current study, we assessed TBRs regarding different lesion types, which was based on distinct calcification and necrosis. These types were further evidenced with gross specimens and microscopic analysis. Our results showed that there were significant TBRs differences between different lesion types, as well as different degree of calcification. Apparently, less calcified lesions had higher TBRs although there were no differences between any degree of necrosis. The higher TBRs value is, the stronger the lesion activity. At the meantime, calcification and necrosis could be evaluated by CT easily. So, TBRs value can be correlated to corresponding lesion types to help professionals to decide which treatment option would be best.
When it came to LME range (18F-FDG uptake region around the lesion), PET/CT and MSS presented no obvious differences no matter which lesion type it was. Interestingly, LME ranges also varied between different lesion types. Generally, less calcification and necrosis meant wider LME range. Although, it is understandable that calcification and necrosis are the ways of death of the parasitic lesion, but, differential degrees of calcification and necrosis as well as integration of them had revealed further insights of AE lesions. In addition, regression between TBRs and LME range indicated by PET/CT and MSS were weak to conclude the relations. It is worth to point out that, even the TBRs is very high, LME range could not be symmetrically wide, because parasitic-host interactions need close contact, and the longer the distance is, the harder the enrichment of host cells or other parenchymal components happen.
Moreover, the LME region may directly affect the experimental outcome when not balanced properly by mimicking real experimental liver tissue with the real control liver tissues. A previous research has studied surrogate markers in distinguishing metabolically active and inactive AE patients[26]. In this study, methodology for sampling was defined as “specimens were taken from the AE lesion area and from a macroscopically normal distant area of liver tissue”, however, the precise area has not been described, but there was a well consideration for control liver tissue acquisition based on pathology. Another recent study sampled the liver tissues with 2 cm line to study Kupffer cell and fibrosis in hepatic AE[7]. Also, no specific leison type heterogeniety was decribed except expressiong that “the liver tissues were taken within 2 cm of the lesion by surgery for the close group, whereas the liver tissues were taken 2 cm outside the lesion for the distance group”. If a 2 cm line has to be chosen to determine the experimental and control liver tissues: (a) it would definitely reduce both of the targeted immune cell number and cell types in cases with narrower LME range than 2 cm; (b) it would also increase them in cases with wider LME range that 2 cm. Meanwhile, some other studies never layed out the sampling areas or scales[27]. Of course, it was major result-influencing factor. So, we strongly recommend that the differentiative line should be based on different lesion types to achieve best performance of liver-based studies for AE.
The potential for resection and whether there is disease dissemination must be assessed carefully by pre-operative imaging techniques[3]. Surgical removal of parasitic lesion plus peri-lesion inflammatory belt is recommended. A western study demonstrated that R0 resection had 2% disease recurrence, whereas, R1 and R2 resections showed 41% of intrahepatic disease progression during follow-up[28]. Another study reported late recurrence even after R0 resection[29]. It also emphasized the importance of R0 resection of AE lesion. However, how wide the peri-lesion inflammatory belt (corresponding to LME) has not been studied based on distinct lesion types. Besides, achieving 2 cm resection margin for every single lesion is not possible in most advanced cases as recommended[3, 4, 28, 30]. For excessive vascular infiltrated lesion or with severe comorbidities, only liver transplantation or ex vivo liver resection and autotransplantation could be selected from the perspective surgical treatment[11, 31–40]. Our data indicated that, different lesion types had different immune cell infiltrated belt. For major/obvious calcified lesions, less than 2 cm resection margin would be satisfactory; for severe necrotic lesion with obvious calcified capsule, less than 1 cm resection margin will be enough. Extra indications for resection margin could also be concluded from this study results.
Objectively speaking, shortcomings of this study were that we were short when enrolling patients which had both PET/CT and MSS data because of different surgical approaches (not all surgeries could provide sufficient liver samples), and some other lesion categories were not included due to unavailability of PET/CT or MSS. Moreover, MSS with 5 mm intervals off the lesion shore prevented us to map the immune cell infiltration with higher resolution. Further, methodology for simulating every spatial SUV digital data would be more helpful to understand the spatial heterogeneity of a lesion. Future insights of LME should be discovered in depth in further researches.